GLP-1s are being prescribed for everything from arthritis to sleep apnea to low testosterone — with almost no evidence they treat any of it. In this episode, I expose the industry-funded research underpinning the semaglutide gold rush, the risks nobody's talking about (including one that affected a quarter of participants in the study used to license the highest dose), and the logical fallacy that's driving doctors to reach for Ozempic no matter what's wrong with you. You deserve to know the truth before you pick up that pen.
Pre-order your copy of No Weigh! here
Got a question for the next podcast? Let me know!
Connect With Me
